Therapeutic drug monitoring in pregnant and postpartum women: Recommendations for SSRIs, lamotrigine, and lithium

Journal of Clinical Psychiatry

Volumn 71, Issue 5, 2010, Pages 649-650

  Deligiannidis, Kristina M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; SEROTONIN UPTAKE INHIBITOR;

ANTICONVULSANT THERAPY; BIPOLAR DISORDER; DEMETHYLATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG MONITORING; DRUG SAFETY; EPILEPSY; FEMALE; HUMAN; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUERPERAL DEPRESSION; PUERPERIUM; REVIEW; SEIZURE;

ANTICONVULSANTS; ANTIMANIC AGENTS; DEPRESSIVE DISORDER; DRUG MONITORING; EPILEPSY; FEMALE; HUMANS; LITHIUM COMPOUNDS; POSTPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS; TRIAZINES;

EID: 77952654128     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10ac06132gre     Document Type: Review

References (27)

1. Yonkers KA, Wisner KL, Stewart DE, et al. Gen Hosp Psychiatry. 2009;31(5):403-413.
2. Fotopoulou C, Kretz R, Bauer S, et al. Epilepsy Res. 2009;85(1):60-64.
3. Yonkers KA, Wisner KL, Stowe Z, et al. Am J Psychiatry. 2004;161(4):608-620.
4. Tuccori M, Testi A, Antonioli L, et al. Clin Ther. 2009;31(pt 1): 1426-1453.
5. Sit DK, Perel JM, Helsel JC, et al. J Clin Psychiatry. 2008;69(4):652-658.
6. Tracy TS, Venkataramanan R, Glover DD, et al. Am J Obstet Gynecol. 2005;192(2):633-639.
7. Wadelius M, Darj E, Frenne G, et al. Clin Pharmacol Ther. 1997;62(4):400-407.
8. Anderson GD. Clin Pharmacokinet. 2005;44(10):989-1008.
9. Heikkinen T, Ekblad U, Kero P, et al. Clin Pharmacol Ther. 2002;72(2):184-191.
10. Heikkinen T, Ekblad U, Palo P, et al. Clin Pharmacol Ther. 2003;73(4):330-337.
11. Ververs FF, Voorbij HA, Zwarts P, et al. Clin Pharmacokinet. 2009;48(10):677-683.
12. Freeman MP, Nolan PE Jr, Davis MF, et al. J Clin Psychopharmacol. 2008;28(6):646-653.
13. DeVane CL, Liston HL, Markowitz JS. Clin Pharmacokinet. 2002;41(15):1247-1266.
14. Hostetter A, Stowe ZN, Strader JR Jr, et al. Depress Anxiety. 2000;11(2):51-57.
15. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Evid Rep Technol Assess (Summ). 2005;(119):1-8.
16. Sabers A, Dam M, A-Rogvi-Hansen B, et al. Acta Neurol Scand. 2004;109(1):9-13.
17. Ohman I, Luef G, Tomson T. Seizure. 2008;17(2):199-202.
18. Pennell PB, Newport DJ, Stowe ZN, et al. Neurology. 2004;62(2): 292-295.
19. Tran TA, Leppik IE, Blesi K, et al. Neurology. 2002;59(2):251-255.
20. Harden CL, Pennell PB, Koppel BS, et al, for the American Epilepsy Society. Neurology. 2009;73(2):142-149.
21. Harlow BL, Vitonis AF, Sparen P, et al. Arch Gen Psychiatry. 2007;64(1):42-48.
22. Linden S, Rich CL. J Clin Psychiatry. 1983;44(10):358-361.
23. Ward S, Wisner KL. J Midwifery Womens Health. 2007;52(1):3-13.
24. Llewellyn A, Stowe ZN, Strader JR Jr. J Clin Psychiatry. 1998;59 (suppl 6):57-64, discussion 65.
25. Committee on Drugs. American Academy of Pediatrics. Pediatrics. 2000;105(4 pt 1):880-887.
26. Newport DJ, Viguera AC, Beach AJ, et al. Am J Psychiatry. 2005;162(11):2162-2170.
27. Malzacher A, Engler H, Drack G, et al. J Perinat Med. 2003;31(4): 340-342.